Ask AI
Karen Reckamp

Karen Reckamp, MD, FASCO

Director, Division of Medical Oncology
Associate Director, Clinical Research
Professor, Department of Medicine
Cedars-Sinai Health Sciences University
Los Angeles, California

Explore Activities by Karen Reckamp

Title
Format
Credit Type
Credits
Talking About Immunotherapy: A Guide for Patients With Early-Stage NSCLC

Content Format:

PDF

Credit Type:

--

Credits:

--
Call To Action: Individualizing Treatment Plans in Resectable Early-Stage NSCLC

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
New Frontiers in Advanced EGFR-Mutated NSCLC Therapy: Targeting HER3 With Novel Agents

Content Format:

Slideset

Credit Type:

--

Credits:

--
New Frontiers in Advanced EGFR-Mutated NSCLC Therapy: Targeting HER3 With Novel Agents

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.75
Optimizing HER3-Targeted Therapy for NSCLC: Strategies for Early Detection and Management of Adverse Events

Content Format:

Slideset

Credit Type:

--

Credits:

--
Optimizing HER3-Targeted Therapy for NSCLC: Strategies for Early Detection and Management of Adverse Events

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.50
Precision in Early-Stage NSCLC Care: ​Community Workshop on the Optimal​ Integration of Biomarker-Driven Therapy

Content Format:

Video

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
HER3-Targeted Therapies for EGFRm NSCLC: Emerging Therapies and Challenges in Treatment

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Precision in Early-Stage NSCLC Care: Community Workshop on the Optimal Integration of Biomarker-Driven Therapy

Content Format:

Slideset

Credit Type:

--

Credits:

--
Evolving Treatment Landscape of EGFR-Mutated Advanced and Metastatic NSCLC: Answers to Frequently Asked Questions

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Expert Perspectives on the Evolving Treatment of EGFR-Mutated Advanced and Metastatic NSCLC

Content Format:

Video

Credit Type:

AMA

Credits:

1.25
Expert Perspectives on the Evolving Treatment of EGFR-Mutated Advanced and Metastatic NSCLC

Content Format:

Slideset

Credit Type:

--

Credits:

--
Immune Checkpoint Inhibitor–Based Combinations for Patients With NSCLC and Acquired Resistance to Immunotherapy

Content Format:

Video

Credit Type:

AMA

Credits:

1.00
Immune Checkpoint Inhibitor–Based Combinations for Patients With NSCLC and Acquired Resistance to Immunotherapy

Content Format:

Slideset

Credit Type:

AMA

Credits:

1.00
Improving Outcomes for Patients With Advanced NSCLC Through the Optimal Integration of HER2-Targeted Antibody–Drug Conjugate Therapy

Content Format:

Slideset

Credit Type:

--

Credits:

--
Key Studies in Lung Cancer: Independent Conference Coverage of ASCO 2023

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
An Expert’s Guide to ASCO 2023: Preview of the Top Abstracts

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--